Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Sala

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Transplantation and Cellular Therapy|May 7, 2023
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell TransplantationSowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, et al.
Leukemia|March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesJohannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Current Research in Translational Medicine|October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
HLA|June 27, 2024
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationElisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Transplantation and Cellular Therapy|May 7, 2023
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell TransplantationSowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, et al.
Leukemia|March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesJohannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Current Research in Translational Medicine|October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
HLA|June 27, 2024
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationElisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
The Journal of Clinical Investigation|May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsAgnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Pageof 9